Nurses Light the Path:
Empowering Patients to Improve Breast Cancer Screening
and Clinical Trial Representation
For women with breast cancer and those at risk, disparities in screening and clinical-trial enrollment exist, particularly among racial and ethnic minority populations. Join Melody Taylor, MSN, RN, CCM and Monique Gary, DO, FACS, FSSO as they discuss strategies to mitigate these disparities. This includes offering patients support, education, and resources to empower them in making informed decisions on these matters.
Featured Faculty:
Melody Taylor, DNP, RN, CCM
Vice-President
Black Nurses Rock
Monique Gary, DO, FACS, FSSO
Breast Surgical Oncologist
Medical Director, Cancer Program
Grand View Health/Penn Cancer Network
Associate Professor of Surgery
Philadelphia College of Osteopathic Medicine
Registration Link:
For women with breast cancer and those at risk, disparities in screening and clinical-trial enrollment exist, particularly among racial and ethnic minority populations. Awareness of these disparities can ensure timely screening practices and help address patient fears and concerns regarding clinical trials that inhibit diverse representation in research. Younger women should be educated on their higher risk for aggressive breast cancer subtypes and empowered to get regular screenings that can aid early detection.
Join an expert panel as they discuss how to reduce disparities and increase equity in clinical trial enrollment. Panelists will also highlight the importance of regular screening for breast cancer and share strategies to provide patients with support, education, and resources to make informed decisions on these topics.
Learning Objectives:
- Demonstrate appropriate screening practices for women at risk of breast cancer
- Describe strategies to address disparities in clinical trial enrollment
- Provide patients with support, education, and resources to make informed decisions regarding screening and clinical trial enrollment
Topics of Interest:
Chapter 1: Supporting Screening Across the Age Continuum
- Addressing increased risk of breast cancer in women of every age
- Susceptibility of younger women to certain subtypes of cancer
- Good screening practices for Black women
- Resources for patients and communities on screening
Chapter 2: Improving Diversity in Breast Cancer Clinical Trials
- Breast cancer incidence vs clinical trial participation in minority populations
- Importance of diverse populations in breast cancer trials
- Patient perspectives on trial participation
- Key areas of unmet need and overview of ongoing trials
Chapter 3: A Nurse’s Moment of Impact: Practical Strategies to Facilitate Education
- Strategies to effectively spread the message about timely screening and advocating for oneself
- Steps to improve clinical trial participation among minority patients
- Engaging other care team members in this mission
- Resources for patient and community education
Full CME Information:
Nurses Light the Path: Empowering Patients to Improve Breast Cancer Screening and Clinical Trial Representation
Jointly provided by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC, in collaboration with Black Nurses Rock
ACKNOWLEDGEMENT
This activity is supported by an independent medical education grant from Daiichi Sankyo, Inc.
DATE OF RELEASE/EXPIRATION
This activity was released on March 8, 2024 and is valid until March 8, 2025. Requests for credit must be made no later than March 8, 2025.
TARGET AUDIENCE
The primary target audience for this activity is Oncology Nursing Professionals (APRN, NP, RN).
STATEMENT OF NEED/PROGRAM OVERVIEW
For women with breast cancer and those at risk, disparities in screening and clinical-trial enrollment exist, particularly among racial and ethnic minority populations. Awareness of these disparities can ensure timely screening practices and help address patient fears and concerns regarding clinical trials that inhibit diverse representation in research. Younger women should be educated on their higher risk for aggressive breast cancer subtypes and empowered to get regular screenings that can aid early detection.
Join an expert panel as they discuss how to reduce disparities and increase equity in clinical trial enrollment. Panelists will also highlight the importance of regular screening for breast cancer and share strategies to provide patients with support, education, and resources to make informed decisions on these topics.
EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:
- Demonstrate appropriate screening practices for women at risk of breast cancer
- Describe strategies to address disparities in clinical trial enrollment
- Provide patients with support, education, and resources to make informed decisions regarding screening and clinical trial enrollment
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CONTINUING EDUCATION
PACE designates this enduring activity for a maximum of .75 nursing contact hours. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ESTIMATED TIME TO COMPLETE
This activity should take approximately 45 minutes to complete.
INSTRUCTIONS TO RECEIVE CREDIT
In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive nursing contact hours participants must receive a score of 75% on the post-test.
HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
FEE INFORMATION & REFUND/CANCELLATION POLICY
There is no fee for this educational activity.
DISCLOSURES
PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships.
| Faculty | Conflicts of Interest |
| Monique Gary, DO, FACS, FSSO
Breast Surgical Oncologist |
Dr. Monique Gary, faculty for this educational activity, has the following relevant financial relationships:
|
| Melody Taylor, MSN, RN, CCM
Vice-President |
Melody Taylor, faculty for this educational activity, has no relevant financial relationships. |
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
CONTACT INFORMATION
Accreditation Support:
For additional information about the accreditation of this activity, please visit https://partnersed.com.
Technical Support:
For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com.
